INCREDB ID : 191
Home >> Investigator Page Previous      Next
Rajiv Phondu Gude, Ph.D.
Principal Investigator 
 
Advanced Centre for Treatment Research and Education in Cancer
Gude Lab
Khanolkar Shodhika, Tata Memorial Centre, Kharghar
Navi Mumbai - 410 210   
Maharashtra   
 
E-mail: rpgude@actrec.gov.in
Phone: +91-22 -27405000
Fax: +91-22 -27412892,93,94
 
URL: http://actrec.gov.in/pi-webpages/RajivGude/drgude.html
 
Area of Specialization:
Molecular Oncology
Publications:

 

1. Jain, M., Ratheesh, A. and Gude, R. P.  Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells. Chemotherapy. 2010.  56, 82-88. [PubMed]
2. Shenoy, V. S., Gude, R. P. and Murthy, R. S.  Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity. Journal of Drug Targeting. 2009.  17, 304-310. [PubMed]
3. Shenoy, V. S., Rajyaguru, T. H., Gude, R. P. and Murthy, R. S.  Studies on paclitaxel-loaded glyceryl monostearate nanoparticles. Journal of Microencapsulation. 2009.  26, 471-478. [PubMed]
4. Dua, P. and Gude, R. P.  Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation. European Journal of Cancer. 2008.  44, 1587-1595. [PubMed]
5. Ratheesh, A., Ingle, A. and Gude, R. P.  Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biology & Therapy. 2007.  6, 1743-1752. [PubMed]
6. Dua, P., Ingle, A. and Gude, R. P.  Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma. International Journal of Cancer. 2007.  121, 1600-1608. [PubMed]
7. Dua, P. and Gude, R. P.  Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Cancer Chemotherapy and Pharmacology. 2006.  58, 195-202. [PubMed]
8. Sant, V. P., Nagarsenker, M. S., Rao, S. G. and Gude, R. P.  Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice. Cancer Biotherapy & Radiopharmaceuticals. 2003.  18, 811-817. [PubMed]
9. Shukla, V. and Gude, R. P.  Amelioration of B16F10 melanoma cells induced oxidative stress in DBA/2 mice by pentoxifylline. Journal of Experimental & Clinical Cancer Research : CR. 2003.  22, 407-410. [PubMed]
10. Shukla, V. and Gude, R. P.  Potentiation of antimetastatic activity of pentoxifylline in B16F10 and B16F1 melanoma cells through inhibition of glutathione content. Cancer Biotherapy & Radiopharmaceuticals. 2003.  18, 559-564. [PubMed]
11. Shukla, V. and Gude, R. P.  Potentiation of lipid peroxidation in B16F10 and B16F1 melanoma cells by caffeine, a methylxanthine derivative: relationship to intracellular glutathione. Chemotherapy. 2003.  49, 71-75. [PubMed]
12. Menon, L. G., Ingle, A. D. and Gude, R. P.  Tumor regression of B16F10 melanoma in vivo by prevention of neovascularization: study on theophylline. Cancer Biotherapy & Radiopharmaceuticals. 2002.  17, 213-217. [PubMed]
13. Gude, R. P., Jadhav, M. G., Rao, S. G. and Jagtap, A. G.  Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer Biotherapy & Radiopharmaceuticals. 2002.  17, 183-192. [PubMed]
14. Gude, R. P., Binda, M. M., Boquete, A. L. and Bonfil, R. D.  Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline. Journal of Cancer Research and Clinical Oncology. 2001.  127, 625-630. [PubMed]
15. Gude, R. P., Menon, L. G. and Rao, S. G.  Effect of Caffeine, a xanthine derivative, in the inhibition of experimental lung metastasis induced by B16F10 melanoma cells. Journal of Experimental & Clinical Cancer Research. 2001.  20, 287-292. [PubMed]
16. Sant, V. P., Nagarsenker, M. S., Rao, S. G. and Gude, R. P.  Enhancement of anti-metastatic activity of pentoxifylline by encapsulation in conventional liposomes and sterically stabilized liposomes in murine experimental B16F10 melanoma model. The Journal of Pharmacy and Pharmacology. 2000.  52, 1461-1466. [PubMed]
17. Gaikwad, S. Y., Jagtap, A. G., Ingle, A. D., Ra, S. G. and Gude, R. P.  Antimetastatic efficacy of niosomal pentoxifylline and its combination with activated macrophages in murine B16F10 melanoma model. Cancer Biotherapy & Radiopharmaceuticals. 2000.  15, 605-615. [PubMed]
18. Gude, R. P., Binda, M. M., Presas, H. L., Klein-Szanto, A. J. and Bonfil, R. D.  Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline. Journal of Biomedical Science. 1999.  6, 133-141. [PubMed]
19. Gude, R. P., Ingle, A. D. and Rao, S. G.  Inhibition of lung homing of B16F10 by pentoxifylline, a microfilament depolymerizing agent. Cancer Letters. 1996.  106, 171-176. [PubMed]
20. Gude, R. P., Chitnis, M. P. and Rao, S. G.  Effect of pentoxifylline, a multidrug resistance reversal agent, on haemopoietic stem cell homing. Cell Biology International. 1994.  18, 79-84. [PubMed]
21. Chitnis, M. P., Menon, R. S. and Gude, R. P.  Effect of Tween 80 on adriamycin cytotoxicity in murine P388 leukemia. Tumori. 1984.  70, 313-315. [PubMed]
22. Chitnis, M. P., Joshi, S. S., Gude, R. P. and Menon, R. S.  Induced resistance in leukaemia L1210 to adriamycin and its cross-resistance to vincristine and bouvardin. Chemotherapy. 1982.  28, 209-212. [PubMed]
 

 

 
Education 
::
Ph.D.
  Last modified on : Dec 10, 2015
India Cancer Research Database has been developed by the Institute of Bioinformatics with funding from the Department of Biotechnology, Government of India.